Literature DB >> 12354389

Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses.

Susumu Nakae1, Yutaka Komiyama, Aya Nambu, Katsuko Sudo, Michiko Iwase, Ikuo Homma, Kenji Sekikawa, Masahide Asano, Yoichiro Iwakura.   

Abstract

Interleukin-17 (IL-17) is a proinflammatory cytokine produced by T cells. The involvement of IL-17 in human diseases has been suspected because of its detection in sera from asthmatic patients and synovial fluids from arthritic patients. In this study, we generated IL-17-deficient mice and investigated the role of IL-17 in various disease models. We found that contact, delayed-type, and airway hypersensitivity responses, as well as T-dependent antibody production, were significantly reduced in the mutant mice, while IL-17 deficiency of donor T cells did not affect acute graft-versus-host reaction. The results suggest that impaired responses were caused by the defects of allergen-specific T cell activation. Our findings indicate that IL-17 plays an important role in activating T cells in allergen-specific T cell-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354389     DOI: 10.1016/s1074-7613(02)00391-6

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  410 in total

1.  A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice.

Authors:  Mushtaq Ahmed; Douglas M Smith; Tarek Hamouda; Javier Rangel-Moreno; Ali Fattom; Shabaana A Khader
Journal:  Vaccine       Date:  2017-07-31       Impact factor: 3.641

Review 2.  Emerging roles of T helper subsets in the pathogenesis of asthma.

Authors:  Douglas M Durrant; Dennis W Metzger
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

3.  IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans.

Authors:  Shinji Kagami; Heather L Rizzo; Stephen E Kurtz; Lloyd S Miller; Andrew Blauvelt
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

4.  Autoimmunity to neuroretina in the concurrent absence of IFN-γ and IL-17A is mediated by a GM-CSF-driven eosinophilic inflammation.

Authors:  So Jin Bing; Phyllis B Silver; Yingyos Jittayasothorn; Mary J Mattapallil; Chi-Chao Chan; Reiko Horai; Rachel R Caspi
Journal:  J Autoimmun       Date:  2020-06-24       Impact factor: 7.094

5.  Roles of interleukin-17 in an experimental Legionella pneumophila pneumonia model.

Authors:  Yoshifumi Kimizuka; Soichiro Kimura; Tomoo Saga; Makoto Ishii; Naoki Hasegawa; Tomoko Betsuyaku; Yoichiro Iwakura; Kazuhiro Tateda; Keizo Yamaguchi
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

6.  Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production.

Authors:  Benjamin J Murdock; Gary B Huffnagle; Michal A Olszewski; John J Osterholzer
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

7.  IL-17 signaling-independent central nervous system autoimmunity is negatively regulated by TGF-beta.

Authors:  Ines Gonzalez-García; Yani Zhao; Songguang Ju; Qin Gu; Lin Liu; Jay K Kolls; Binfeng Lu
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Anti-inflammatory role of IL-17 in experimental autoimmune uveitis.

Authors:  Yan Ke; Ke Liu; Guo-Qiang Huang; Yan Cui; Henry J Kaplan; Hui Shao; Deming Sun
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 9.  IL-17F: regulation, signaling and function in inflammation.

Authors:  Seon Hee Chang; Chen Dong
Journal:  Cytokine       Date:  2009-02-23       Impact factor: 3.861

10.  TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.

Authors:  Reiko Horai; Akiko Nakajima; Katsuyoshi Habiro; Motoko Kotani; Susumu Nakae; Taizo Matsuki; Aya Nambu; Shinobu Saijo; Hayato Kotaki; Katsuko Sudo; Akihiko Okahara; Hidetoshi Tanioka; Toshimi Ikuse; Naoto Ishii; Pamela L Schwartzberg; Ryo Abe; Yoichiro Iwakura
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.